By John Stang
Nonproliferation advocates and medical isotopes companies hope to persuade the U.S. Nuclear Regulatory Commission that a Belgian company should not receive additional highly enriched uranium from the United States to make its own isotopes.
The regulator…                    
                    
                    
                                        
                    
                
                    RadWaste Monitor Vol. 12 No. 38
Visit Archives | Return to Issue PDF
            
            
            Visit Archives | Return to Issue PDF
                RadWaste & Materials Monitor
            
            
        Article 2 of 9
             October 04, 2019
            Isotope Companies, Nonproliferation Advocates Oppose New HEU Export License
        Partner Content
    
    
			Jobs